New diabetes clinical trial: A Phase I Study to Evaluate the PK and PD Profiles of GZR102 Injection Versus GZR4 Injection and GZR18 Injection Given Separately in Chinese Adult Overweight Subjects

Published on: May 15, 2025 at 11:00PM
Conditions: Type 2 Diabetes
Interventions: Drug: GZR102 injection; Drug: GZR4 injection; Drug: GZR18 injection
Sponsors: Gan & Lee Pharmaceuticals.
Not yet recruiting
https://ift.tt/hWqodw7